Black Friday saleUp to 70% OFF
CCC

CLEO DIAGNOSTICS LTD

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

COV chart


Full chart

Key stats


Market capitalization
‪44.98 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.030 AUD
Net income (FY)
‪−3.76 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
—
Beta (1Y)
−0.09

About CLEO DIAGNOSTICS LTD


Sector
Health Technology
Industry
Medical Specialties
CEO
Richard Allman
Website
cleodx.com
Headquarters
Melbourne
Founded
2021
ISIN
AU0000288045
FIGI
BBG01HBC36T4
CLEO Diagnostics Ltd. is a medical diagnostics/devices company which mainly focuses on the development of non-invasive blood based IVD tests to detect the presence, and recurrence, of ovarian cancer. The company developed a three-phased product development strategy that will deliver three related tests for ovarian cancer detection: Triage Test-a pre-surgical test, Recurrence Test-a post-surgical test and Screening Test-a screening test to identify early-stage ovarian cancer. CLEO Diagnostics was founded on November 30, 2021 and is headquartered in Melbourne, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

COV news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of COV is 0.350 AUD — it has decreased by −1.43% in the past 24 hours. Watch CLEO DIAGNOSTICS LTD stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange CLEO DIAGNOSTICS LTD stocks are traded under the ticker COV.
COV stock has fallen by −5.48% compared to the previous week, the month change is a −4.17% fall, over the last year CLEO DIAGNOSTICS LTD has showed a 94.44% increase.
COV reached its all-time high on Aug 14, 2024 with the price of 0.480 AUD, and its all-time low was 0.140 AUD and was reached on Jan 30, 2024. View more price dynamics on COV chart.
See other stocks reaching their highest and lowest prices.
COV stock is 2.90% volatile and has beta coefficient of −0.09. Track CLEO DIAGNOSTICS LTD stock price on the chart and check out the list of the most volatile stocks — is CLEO DIAGNOSTICS LTD there?
Yes, you can track CLEO DIAGNOSTICS LTD financials in yearly and quarterly reports right on TradingView.
COV net income for the last half-year is ‪−1.15 M‬ AUD, while the previous report showed ‪−2.61 M‬ AUD of net income which accounts for 56.04% change. Track more CLEO DIAGNOSTICS LTD financial stats to get the full picture.
No, COV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, COV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CLEO DIAGNOSTICS LTD stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CLEO DIAGNOSTICS LTD technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CLEO DIAGNOSTICS LTD stock shows the neutral signal. See more of CLEO DIAGNOSTICS LTD technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.